Brokerages Set Trevi Therapeutics, Inc. (NASDAQ:TRVI) PT at $17.56
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Get Free Report) has received an average recommendation of “Buy” from the ten brokerages that are currently covering the company, Marketbeat reports. Seven equities research analysts have rated the stock with a buy recommendation and three have given a strong buy recommendation to the company. The average 1-year price objective […]
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Get Free Report) has received an average recommendation of “Buy” from the ten brokerages that are currently covering the company, Marketbeat reports. Seven equities research analysts have rated the stock with a buy recommendation and three have given a strong buy recommendation to the company. The average 1-year price objective […]
